Influenza Epidemiology and Diseases Management

Influenza occurs in distinct outbreaks of varying extent every year. The influenza epidemiology pattern reflects the changing nature of the antigenic properties of influenza viruses, and their subsequent spread depends upon multiple factors, including transmissibility of the virus and the susceptibility of the population. Influenza A viruses, in particular, has a remarkable ability to undergo periodic changes in the antigenic characteristics of their envelope glycoproteins, the hemagglutinin and the neuraminidase. Influenza is a highly infectious disease which can occur as a pandemic, epidemic, outbreak and in form of sporadic cases. While in home isolation, patients and other household members should be given infection control instructions, including frequent hand washing with soap and water. Use alcohol-based hand gels (containing at least 60% alcohol) when soap and water are not available and hands are not visibly dirty. Patients with H1N1 influenza should wear a face mask when within 6 feet of others at home.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.  

Vaccine efficacy studies can measure outcomes beyond disease attack rates, including hospitalizations, medical visits, and costs. The external validity of the results of a vaccine efficacy study to a larger, non-study population may be lowered by differences between the study cohort and the population as a whole. H1N1 Influenza, an acute contagious respiratory infection caused by orthomyxoviruses A, B, and C, occurs in local outbreaks, epidemics and pandemics. Differences in the morphology and antigen patterns for these viruses account for the differences in virulence and immunity. Influenza A is virulent, B is mild, and C is non-virulent. Swine influenza virus may spread from swine to man (recycling of human A virus), causing epidemics and pandemics. 

 With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

  • Rapid Containment of Pandemic Influenza: Strategy and Protocol
  • Global Outbreak and Alert Response Network: A(H1N1) Initial Alert and Response
  • Country Operation Support and logistics Coordination: Antiviral Stockpile Deployment
  • EMS (Event Management System)
  • Monitoring and Tracking Global and Regional Progression, Transmission, and Impact of the Pandemic
  • Generating and Sharing Authoritative Information to Support Country Interventions and Mitigation Strategies

Related Conference of Influenza Epidemiology and Diseases Management

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA

Influenza Epidemiology and Diseases Management Conference Speakers

Recommended Sessions

Related Journals

Are you interested in